
In the context of a litigation procedure opened before the Autorité, Sony offered commitments to make its licensing policy more transparent to third parties wishing to manufacture and market compatible controllers with the Playstation 4 on the French market, the French regulator reported.
The Playstation 4 console, launched in November 2013, is the best-selling home console in France and Europe.
In order to play the games available on this console, players use controllers compatible with the console.
In their preliminary assessment, the investigation services found that, as of November 2015, Sony has deployed a device aiming at fighting against counterfeit controllers.
In response to these competition concerns, Sony offers to establish a set of objective criteria and technical and quality standards (or to clarify existing ones if necessary), to which any interested third party must comply in order to participate in the official program license granting of compatible controllers with the Playstation 4 console on the French market, and to apply them on a non-discriminatory basis.
Full Content: Autorite de la Concurrence
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas